MRKR Marker Therapeutics, Inc.
Nasdaq · SEC CIK 1094038 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 40 since 2021-12-09, latest 2025-11-19
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| No open-market trades in the last year. | |||
Transactions 11
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-12-26 | 2024-12-23 | MRKR | ELMS STEVE | Dir | P - Purchase | $3.20 | +11.1K | 325.4K | +4% | +$35.5K |
| 2024-12-23 | 2024-12-23 | MRKR | NEA Partners 16, L.P. | 10% | P - Purchase | $3.20 | +554.2K | 1.63M | +52% | +$1.77M | |
| DMI | 2023-06-08 | 2021-03-25 | MRKR | Eansor Norman David | Dir | G - Gift | $0.00 | +14.3K | 7,142 | New | $0 |
| D | 2023-06-08 | 2021-03-25 | MRKR | Eansor Norman David | Dir | G - Gift | $0.00 | -14.3K | 2,428 | -85% | $0 |
| D | 2023-06-08 | 2021-03-16 | MRKR | Eansor Norman David | Dir | P - Purchase | $17.50 | +14.3K | 16.7K | +588% | +$250.0K |
| 2022-03-28 | 2022-03-24 | MRKR | Vera Juan | CSO, COO, Dir | A - Grant | $0.00 | +140.8K | 2.71M | +5% | $0 | |
| 2022-03-28 | 2022-03-24 | MRKR | Vera Juan | CSO, COO, Dir | F - Tax | $0.48 | -33.5K | 2.67M | -1% | -$16.1K | |
| 2022-03-28 | 2022-03-24 | MRKR | Hoang Peter L. | Pres, CEO, Dir | A - Grant | $0.00 | +199.1K | 531.7K | +60% | $0 | |
| 2022-03-28 | 2022-03-24 | MRKR | Hoang Peter L. | Pres, CEO, Dir | F - Tax | $0.48 | -48.4K | 483.3K | -9% | -$23.2K | |
| 2022-03-28 | 2022-03-24 | MRKR | Kim Anthony H. | CFO | A - Grant | $0.00 | +150.5K | 150.5K | New | $0 | |
| 2022-03-28 | 2022-03-24 | MRKR | Kim Anthony H. | CFO | F - Tax | $0.48 | -36.1K | 114.4K | -24% | -$17.3K |
Purchase Sale Sale after option exercise All abbreviations